Condition 1: palmoplantar wart. Condition 2: Common wart. Plantar wart Other viral warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of 16 years of age and higher Common type warts Palmoplantar type warts
Exclusion criteria
Exclusion criteria: Patients with more than 5 lesions Pregnancy Lactation Patients with vascular, cardiovascular, hepatic, and chronic kidney disease Patients with hypersensitivity to 5-flurouracil, lidocaine, epinephrine, or cryotherapy Beta-blocker drug consumption Immunocompromised patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete clinical cure. Timepoint: At the beginning of treatment, and weeks 1, 2, 3, 4, 5, 6, 8, and 14. Method of measurement: Lesion size calculation by ruler and dermatoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain during treatment. Timepoint: Weeks 1, 2, 3, 4, 5, 6. Method of measurement: Pain illustrated numerical rating scale.;Quality of life. Timepoint: At the beginning of treatment, and the end of treatment. Method of measurement: Dermatology quality of life index Persian version. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences